Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chibuzor Uchea, Sunil Sarda, Timothy Schulz-Utermoehl, Stewart Owen & Kevin J. Chipman. (2013) In vitro models of xenobiotic metabolism in trout for use in environmental bioaccumulation studies. Xenobiotica 43:5, pages 421-431.
Read now
Read now
Ines A Pieper & Martin Bertau. (2010) Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage. Expert Opinion on Drug Metabolism & Toxicology 6:6, pages 747-760.
Read now
Read now
O. Pelkonen & M. Turpeinen. (2007) extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 37:10-11, pages 1066-1089.
Read now
Read now
G. I. Somers, M. K. Bayliss & J. B. Houston. (2007) The metabolism of the 5HT3 antagonists, ondansetron, alosetron and GR87442 II: Investigation into the in vitro methods used to predict the in vivo hepatic clearance of ondansetron, alosetron and GR87442 in the rat, dog and human. Xenobiotica 37:8, pages 855-869.
Read now
Read now
A.-K. Sohlenius-Sternbeck & S. Schmidt. (2005) Impaired glutathione-conjugating capacity by cryopreserved human and rat hepatocytes. Xenobiotica 35:7, pages 727-736.
Read now
Read now
Marc Vermeir, Pieter Annaert, Rao NVS Mamidi, Dirk Roymans, Willem Meuldermans & Geert Mannens. (2005) Cell-based models to study hepatic drug metabolism and enzyme induction in humans. Expert Opinion on Drug Metabolism & Toxicology 1:1, pages 75-90.
Read now
Read now
E. Floby, S. Briem, Y. Terelius & A.-K. Sohlenius-Sternbeck. (2004) Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations. Xenobiotica 34:11-12, pages 949-959.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
Articles from other publishers (60)
Abdel-Rahim S. Ibrahim, Mai K. Mansour, Mohammed M.A. Ahmed, Roland Ulber & Ahmed Zayed. (2023) Metabolism of natural and synthetic bioactive compounds in Cunninghamella fungi and their applications in drug discovery. Bioorganic Chemistry 140, pages 106801.
Crossref
Crossref
Diana Tzankova, Denitsa Aluani, Magdalena Kondeva-Burdina, Maya Georgieva, Stanislava Vladimirova, Lily Peikova & Virginia Tzankova. (2022) Antioxidant Properties, Neuroprotective Effects and in Vitro Safety Evaluation of New Pyrrole Derivatives. Pharmaceutical Chemistry Journal 55:12, pages 1310-1319.
Crossref
Crossref
. 2020. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables.
Kiani, Ranaghan, Jabeen & Mulholland. (2019) Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors. International Journal of Molecular Sciences 20:18, pages 4468.
Crossref
Crossref
Tom S. Chan, Hongbin Yu, Amanda Moore, Salman R. Khetani & Donald Tweedie. (2019) Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac. Drug Metabolism and Disposition 47:1, pages 58-66.
Crossref
Crossref
Ajit Dash & William R. Proctor. 2019. Microfluidic Cell Culture Systems. Microfluidic Cell Culture Systems
159
186
.
Tatsuyuki Kanamori, Yuko Togawa-Iwata, Hiroki Segawa, Tadashi Yamamuro, Kenji Kuwayama, Kenji Tsujikawa & Hiroyuki Inoue. (2018) Use of hepatocytes isolated from a liver-humanized mouse for studies on the metabolism of drugs: application to the metabolism of fentanyl and acetylfentanyl. Forensic Toxicology 36:2, pages 467-475.
Crossref
Crossref
Min-Ho Nam, Moosung Park, Hyeri Park, Youngjae Kim, Seulki Yoon, Vikram Shahaji Sawant, Ji Won Choi, Jong-Hyun Park, Ki Duk Park, Sun-Joon Min, C. Justin Lee & Hyunah Choo. (2017) Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson’s Disease. ACS Chemical Neuroscience 8:7, pages 1519-1529.
Crossref
Crossref
Arundhati Mandal, Sheena Raju & Chandra Viswanathan. (2015) Long-term culture and cryopreservation does not affect the stability and functionality of human embryonic stem cell-derived hepatocyte-like cells. In Vitro Cellular & Developmental Biology - Animal 52:2, pages 243-251.
Crossref
Crossref
Li Di & Edward H. Kerns. 2016. Drug-Like Properties. Drug-Like Properties
371
386
.
Chibuzor Uchea, Stewart F. Owen & J. Kevin Chipman. (2015) Functional xenobiotic metabolism and efflux transporters in trout hepatocyte spheroid cultures. Toxicology Research 4:2, pages 494-507.
Crossref
Crossref
Tom S. Chan, Hongbin Yu, Amanda Moore, Salman R. Khetani & Donald Tweedie. (2013) Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac. Drug Metabolism and Disposition 41:12, pages 2024-2032.
Crossref
Crossref
Jian YinHongxia QiuJing DaiYanhua LuRong ZhaoLi ChenQin Meng. (2013) Prediction of hepatic plasma clearance in vivo from gel-entrapped rat and human hepatocytes. Canadian Journal of Physiology and Pharmacology 91:2, pages 178-186.
Crossref
Crossref
Pius Fasinu, Yahya E. Choonara, Riaz A. Khan, Lisa C. Du Toit, Pradeep Kumar, Valence M. K. Ndesendo & Viness Pillay. (2013) Flavonoids and Polymer Derivatives as CYP3A4 Inhibitors for Improved Oral Drug Bioavailability. Journal of Pharmaceutical Sciences 102:2, pages 541-555.
Crossref
Crossref
Jong H. Sung, Mandy B. Esch, Jean-Matthieu Prot, Christopher J. Long, Alec Smith, James J. Hickman & Michael L. Shuler. (2013) Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab on a Chip 13:7, pages 1201.
Crossref
Crossref
Angela Dudda & Gert Ulrich Kuerzel. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1053
1094
.
Alexander V. LyubimovMurali Subramanian & Timothy S. Tracy. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
27
.
Cindy Q. Xia, Chuang Lu & Suresh K. Balani. 2011. Oral Bioavailability. Oral Bioavailability
475
491
.
Tatsuyuki Kanamori, Kenji Kuwayama, Kenji Tsujikawa, Hajime Miyaguchi, Yuko Togawa-Iwata & Hiroyuki Inoue. (2011) A model system for prediction of the in vivo metabolism of designer drugs using three-dimensional culture of rat and human hepatocytes. Forensic Toxicology 29:2, pages 142-151.
Crossref
Crossref
Shufang Zhang, Wenhao Tong, Baixue Zheng, Thomas A.K. Susanto, Lei Xia, Chi Zhang, Abhishek Ananthanarayanan, Xiaoye Tuo, Rashidah B. Sakban, Ruirui Jia, Ciprian Iliescu, Kah-Hin Chai, Michael McMillian, Shali Shen, Hwaliang Leo & Hanry Yu. (2011) A robust high-throughput sandwich cell-based drug screening platform. Biomaterials 32:4, pages 1229-1241.
Crossref
Crossref
Arnaud Lacoste & Mark Burcin. 2010. Human Stem Cell Technology and Biology. Human Stem Cell Technology and Biology
353
365
.
Zhi-kun Li & Qi Zhou. (2010) Cellular models for disease exploring and drug screening. Protein & Cell 1:4, pages 355-362.
Crossref
Crossref
K. Wilson. 2013. Principles and Techniques of Biochemistry and Molecular Biology. Principles and Techniques of Biochemistry and Molecular Biology
709
735
.
B. Andria, A. Bracco, G. Cirino & R. A. F. M. Chamuleau. (2010) Liver Cell Culture Devices. Cell Medicine 1:1, pages 55-70.
Crossref
Crossref
Urban Fagerholm. (2007) Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance. Journal of Pharmacy and Pharmacology 59:6, pages 803-828.
Crossref
Crossref
Ruchi Sharma, Sebastian Greenhough, Claire N. Medine & David C. Hay. (2010) Three-Dimensional Culture of Human Embryonic Stem Cell Derived Hepatic Endoderm and Its Role in Bioartificial Liver Construction. Journal of Biomedicine and Biotechnology 2010, pages 1-12.
Crossref
Crossref
John R. Atack, Karen A. Maubach, Keith A. Wafford, Desmond O'Connor, A. David Rodrigues, David C. Evans, F. David Tattersall, Mark S. Chambers, Angus M. MacLeod, Wai-Si Eng, Christine Ryan, Eric Hostetler, Sandra M. Sanabria, Raymond E. Gibson, Stephen Krause, H. Donald Burns, Richard J. Hargreaves, Nancy G. B. Agrawal, Ruth M. McKernan, M. Gail Murphy, Kevin Gingrich, Gerard R. Dawson, Donald G. Musson & Kevin J. Petty. (2009)
In Vitro and in Vivo Properties of 3-
tert
-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1
H
-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-
d
]-[1,2,4]triazine (MRK-016), a GABA
A
Receptor α5 Subtype-Selective Inverse Agonist
. Journal of Pharmacology and Experimental Therapeutics 331:2, pages 470-484.
Crossref
Crossref
Angelika Langsch, Shibashish Giri, Ali Acikgöz, Inka Jasmund, Bernd Frericks & Augustinus Bader. (2009) Interspecies difference in liver-specific functions and biotransformation of testosterone of primary rat, porcine and human hepatocyte in an organotypical sandwich culture. Toxicology Letters 188:3, pages 173-179.
Crossref
Crossref
Miia Turpeinen, Ari Tolonen, Christophe Chesne, André Guillouzo, Jouko Uusitalo & Olavi Pelkonen. (2009) Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. Toxicology in Vitro 23:4, pages 748-753.
Crossref
Crossref
Catharina Ellerström, Petter Björquist, Peter Sartipy, Johan Hyllner & Raimund Strehl. 2009. Emerging Technology Platforms for Stem Cells. Emerging Technology Platforms for Stem Cells
417
437
.
Kati S. Hakala, Marek Link, Barbora Szotakova, Lenka Skalova, Risto Kostiainen & Raimo A. Ketola. (2008) Characterization of metabolites of sibutramine in primary cultures of rat hepatocytes by liquid chromatography–ion trap mass spectrometry. Analytical and Bioanalytical Chemistry 393:4, pages 1327-1336.
Crossref
Crossref
Chih-Hsiu Yin, Wannhsin Chen, Chang-Chun Hsiao, Chao-Long Chen & Wen-Teng Wu. (2008) Improving albumin production of hepatic lineage cells from mouse embryonic stem cells in vitro. Biochemical Engineering Journal 39:3, pages 435-442.
Crossref
Crossref
Nancy ChengEliane WauthierL.M. Reid. (2008)
Mature Human Hepatocytes from
Ex Vivo
Differentiation of Alginate-Encapsulated Hepatoblasts
. Tissue Engineering Part A 14:1, pages 1-7.
Crossref
Crossref
Nancy Cheng, Eliane Wauthier & L.M. Reid. (2008)
Mature Human Hepatocytes from
Ex Vivo
Differentiation of Alginate-Encapsulated Hepatoblasts
. Tissue Engineering 14:1, pages 1-7.
Crossref
Crossref
Caroline Améen, Raimund Strehl, Petter Björquist, Anders Lindahl, Johan Hyllner & Peter Sartipy. (2008) Human embryonic stem cells: Current technologies and emerging industrial applications. Critical Reviews in Oncology/Hematology 65:1, pages 54-80.
Crossref
Crossref
Edward H. Kerns & Li Di. 2008. Drug-like Properties: Concepts, Structure Design and Methods. Drug-like Properties: Concepts, Structure Design and Methods
329
347
.
Peter Sartipy, Petter Björquist, Raimund Strehl & Johan Hyllner. (2007) The application of human embryonic stem cell technologies to drug discovery. Drug Discovery Today 12:17-18, pages 688-699.
Crossref
Crossref
Stephanie Schmitmeier, Angelika Langsch, Wolfgang Schmidt-Heck, Inka Jasmund & Augustinus Bader. (2007) Improvement of metabolic performance of primary hepatocytes in hyperoxic cultures by vitamin C in a novel small-scale bioreactor. Journal of Membrane Science 298:1-2, pages 30-40.
Crossref
Crossref
Diana Jung, Marieke G. L. Elferink, Frans Stellaard & Geny M. M. Groothuis. (2007) Analysis of bile acid-induced regulation of FXR target genes in human liver slices. Liver International 27:1.
Crossref
Crossref
Stephanie Schmitmeier, Angelika Langsch, Inka Jasmund & Augustinus Bader. (2006) Development and characterization of a small-scale bioreactor based on a bioartificial hepatic culture model for predictive pharmacological in vitro screenings. Biotechnology and Bioengineering 95:6, pages 1198-1206.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2006) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 3:10, pages 1053-1101.
Crossref
Crossref
Gisela Werle-Schneider, Andreas Wölfelschneider, Marie Charlotte von Brevern, Julia Scheel, Thorsten Storck, Dieter Müller, Reinhild Glöckner, Helmut Bartsch & Matthias Bartelmann. (2016)
Gene Expression Profiles in Rat Liver Slices Exposed to Hepatocarcinogenic Enzyme Inducers, Peroxisome Proliferators, and 17
α
-Ethinylestradiol
. International Journal of Toxicology 25:5, pages 379-395.
Crossref
Crossref
J.S. Kulkarni & A. Khanna. (2006) Functional hepatocyte-like cells derived from mouse embryonic stem cells: A novel in vitro hepatotoxicity model for drug screening. Toxicology in Vitro 20:6, pages 1014-1022.
Crossref
Crossref
Angela Dudda & Gert Ulrich Kürzel. 2006. Drug Discovery and Evaluation. Drug Discovery and Evaluation
493
520
.
Nicoline Treijtel, Hanneke van Helvoort, Arjan Barendregt, Bas J. Blaauboer & Jan C. H. van Eijkeren. (2005) THE USE OF SANDWICH-CULTURED RAT HEPATOCYTES TO DETERMINE THE INTRINSIC CLEARANCE OF COMPOUNDS WITH DIFFERENT EXTRACTION RATIOS: 7-ETHOXYCOUMARIN AND WARFARIN. Drug Metabolism and Disposition 33:9, pages 1325-1332.
Crossref
Crossref
T. Kanamori, K. Tsujikawa, Y. Ohmae, Y.T. Iwata, H. Inoue, T. Kishi, T. Nakahama & Y. Inouye. (2005) A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. Forensic Science International 148:2-3, pages 131-137.
Crossref
Crossref
Toshiro NiwaToshifumi ShiragaYasuo Ohno & Akira Kagayama. (2005) Interindividual Variability in 5-Fluorouracil Metabolism and Procainamide N-Acetylation in Human Liver Cytosol. Biological and Pharmaceutical Bulletin 28:6, pages 1071-1074.
Crossref
Crossref
Nicoline Treijtel, Arjan Barendregt, Andreas P. Freidig, Bas J. Blaauboer & Jan C. H. van Eijkeren. (2004) MODELING THE IN VITRO INTRINSIC CLEARANCE OF THE SLOWLY METABOLIZED COMPOUND TOLBUTAMIDE DETERMINED IN SANDWICH-CULTURED RAT HEPATOCYTES. Drug Metabolism and Disposition 32:8, pages 884-891.
Crossref
Crossref
M Bayliss & D Cross. 2004. A Handbook of Bioanalysis and Drug Metabolism. A Handbook of Bioanalysis and Drug Metabolism.
Sidney Green & Alan M. Goldberg. (2019) TestSmart and Toxic Ignorance. Alternatives to Laboratory Animals 32:1_suppl, pages 359-363.
Crossref
Crossref
Z. E. Wilson, A. Rostami-Hodjegan, J. L. Burn, A. Tooley, J Boyle, S. W. Ellis & G. T. Tucker. (2003) Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. British Journal of Clinical Pharmacology 56:4, pages 433-440.
Crossref
Crossref
Esther F.A Brandon, Christiaan D Raap, Irma Meijerman, Jos H Beijnen & Jan H.M Schellens. (2003) An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicology and Applied Pharmacology 189:3, pages 233-246.
Crossref
Crossref
Gary W. Caldwell, Zhengyin Yan, John A. Masucci, William Hageman, Gregory Leo & David M. Ritchie. (2012) Applied Pharmacokinetics in Drug Development. Pharmaceutical Development and Regulation 1:2, pages 117-132.
Crossref
Crossref
Patricia Silva Melo, Horacinna Maria de Medeiros Cavalcante, José Maria Barbosa-Filho, Margareth de Fátima Formiga Melo Diniz, Isac Almeida de Medeiros & Marcela Haun. (2003) Warifteine and milonine, alkaloids isolated from Cissampelos sympodialis Eichl: cytotoxicity on rat hepatocyte culture and in V79 cells. Toxicology Letters 142:1-2, pages 143-151.
Crossref
Crossref
Collen M Masimirembwa, Ulf Bredberg & Tommy B Andersson. (2003) Metabolic Stability for Drug Discovery and Development. Clinical Pharmacokinetics 42:6, pages 515-528.
Crossref
Crossref
. 2003. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies
1
40
.
Vikram Arora, Melissa L. Cate, Chandramallika Ghosh & Patrick L. Iversen. (2002) Phosphorodiamidate Morpholino Antisense Oligomers Inhibit Expression of Human Cytochrome P450 3A4 and Alter Selected Drug Metabolism. Drug Metabolism and Disposition 30:7, pages 757-762.
Crossref
Crossref
T. Lavé, O. Luttringer, J. Zuegge, G. Schneider, P. Coassolo & F.-P. Theil. 2002. Pharmacokinetic Challenges in Drug Discovery. Pharmacokinetic Challenges in Drug Discovery
81
104
.
Jochen Zuegge, Gisbert Schneider, Philippe Coassolo & Thierry Lav??. (2001) Prediction of Hepatic Metabolic Clearance. Clinical Pharmacokinetics 40:7, pages 553-563.
Crossref
Crossref
Sean Ekins, Barbara J. Ring, James Grace, Donna J. McRobie-Belle & Steven A. Wrighton. (2000) Present and future in vitro approaches for drug metabolism. Journal of Pharmacological and Toxicological Methods 44:1, pages 313-324.
Crossref
Crossref